Coeliac Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your blood tests for certain antibodies related to celiac disease (anti-tissue transglutaminase and antiendomysium antibodies) have come back negative
- A gut examination has shown that the lining of your small intestine is normal, with no damage to the tiny finger-like structures (villi) that help absorb nutrients
- Allergy tests for wheat (such as a skin prick test or blood test) have come back negative, ruling out a traditional wheat allergy
- You have been monitored for more than 12 months since first being diagnosed with your condition
- You have had at least two check-up appointments during that monitoring period
- Your digestive symptoms improved when you stopped eating certain foods, including wheat, cow's milk, eggs, tomatoes, chocolate, or other foods that seemed to cause problems
- Your symptoms came back during a controlled, blinded food challenge test where you were given wheat without knowing it (confirm with trial site)
Who may not be able to join:
- You are under 18 years of age
- A special laboratory test on a sample taken from your small intestine showed a positive result for a certain antibody (EmA), even if the gut lining otherwise looked normal (confirm with trial site)
- You have already removed wheat from your diet on your own and are not willing to reintroduce it before the study begins
- You have another known digestive condition, such as Crohn's disease
- You are currently taking steroid medications or antihistamines
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Antonio Carroccio, PhD, University of Palermo
Phone: +390916552884
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Inflammatory response to wheat genotypes by PBMC of NCWS patients and healthy control subjects.; Inflammatory response to wheat genotypes by rectal immunocytes of NCWS patients and healthy control subjects.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.